Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Cruz

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Frontiers in Oncology|April 27, 2019
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against CancerShabnum Patel, Rachel A Burga, Allison B Powell, et al.
Cytotherapy|June 6, 2023
Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticlesElizabeth E Sweeney, Palak Sekhri, Deepti Telaraja, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2022
The generation and application of antigen-specific T cell therapies for cancer and viral-associated diseaseAmy B Hont, Allison B Powell, Danielle K Sohai, et al.
Clinical Genetics|May 3, 2006
Cholesteryl ester transfer protein gene mutations in Brazilian hyperalphalipoproteinemiaD B Kaplan, R Schreiber, H C F Oliveira, et al.
Bioengineering & Translational Medicine|May 31, 2024
Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapyElizabeth E Sweeney, Palak Sekhri, Nethaji Muniraj, et al.
Research Square|June 10, 2024
Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in CancerErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
International Journal of Nanomedicine|July 31, 2023
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIVJoshua Ghofrani, Allan Bowen, Jie Chen, et al.
Molecular Therapy. Methods & Clinical Development|October 2, 2020
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIVAllison B Powell, Yanqin Ren, Maria Korom, et al.
Cytotherapy|May 5, 2011
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantationPatrick J Hanley, Donald R Shaffer, Conrad R Y Cruz, et al.
Cytotherapy|May 19, 2022
Comparable transforming growth factor beta-mediated immune suppression in ex vivo-expanded natural killer cells from cord blood and peripheral blood: implications for adoptive immunotherapyKajal Chaudhry, Ehsan Dowlati, Mark D Long, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|April 27, 2019
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against CancerShabnum Patel, Rachel A Burga, Allison B Powell, et al.
Cytotherapy|June 6, 2023
Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticlesElizabeth E Sweeney, Palak Sekhri, Deepti Telaraja, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2022
The generation and application of antigen-specific T cell therapies for cancer and viral-associated diseaseAmy B Hont, Allison B Powell, Danielle K Sohai, et al.
Clinical Genetics|May 3, 2006
Cholesteryl ester transfer protein gene mutations in Brazilian hyperalphalipoproteinemiaD B Kaplan, R Schreiber, H C F Oliveira, et al.
Bioengineering & Translational Medicine|May 31, 2024
Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapyElizabeth E Sweeney, Palak Sekhri, Nethaji Muniraj, et al.
Research Square|June 10, 2024
Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in CancerErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
International Journal of Nanomedicine|July 31, 2023
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIVJoshua Ghofrani, Allan Bowen, Jie Chen, et al.
Molecular Therapy. Methods & Clinical Development|October 2, 2020
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIVAllison B Powell, Yanqin Ren, Maria Korom, et al.
Cytotherapy|May 5, 2011
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantationPatrick J Hanley, Donald R Shaffer, Conrad R Y Cruz, et al.
Cytotherapy|May 19, 2022
Comparable transforming growth factor beta-mediated immune suppression in ex vivo-expanded natural killer cells from cord blood and peripheral blood: implications for adoptive immunotherapyKajal Chaudhry, Ehsan Dowlati, Mark D Long, et al.
Pageof 10